Starboard Value LP (together with its affiliates, "Starboard"), a stockholder of Bristol-Myers Squibb Company ("Bristol-Myers" or the "Company")(NYSE: BMY) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Hedge Funds Mergers and Acquisitions

Starboard Issues Investor Presentation Opposing Bristol-Myers Squibb's Ill-Advised Proposed Acquisition of CelgeneMarch 19, 2019 7:00 AM Bristol-Myers Squibb (BMY) Highlights Significant Benefits of Pending Transaction with Celgene (CELG)March 19, 2019 7:00 AM Bristol-Myers Squibb Files Investor Presentation Highlighting Significant Benefits of Pending Transaction with CelgeneMarch 19, 2019 6:59 AM